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ABSTRACT
Background: Laparoscopic anti-reflux surgery has
been shown to be superior to medical management for
treatment of complicated gastroesophageal reflux disease
(GERD). This study encompasses 100 consecutive
patients undergoing laparoscopic Nissen-Rossetti or
Toupet fundoplications for GERD refractory to medical
management.
Study Design: All 100 patients had failed maximum med-
ical management (behavioral and dietary modifications,
antacids, and H2 and acid PUMP blockers). All patients
underwent esophagogastroduodenoscopy with biopsy
prior to surgery. Ninety-eight patients had esophageal
manometry to evaluate the lower esophageal sphincter
pressures and determine the amplitude of contractions of
the body of the esophagus. Twenty-four hour pH studies
were used selectively when the preceding studies were
equivocal.
Results: All 100 patients' surgeries were accomplished
laparoscopically. The mortality rate was zero. The post-
operative complication rate was 2%. The average hospi-
tal stay was 1.85 days. Follow-up was achieved in 98%.
The mean follow-up was 17.6 months. All patients had
significant improvement of their symptoms. No patients
have long-term dysphagia.
Conclusions: The study demonstrates that laparoscopic
anti-reflux surgery can be safely and effectively accom-
plished in the community hospital setting.
Key Words: Laparoscopic, Surgery, Fundoplication,
Nissen, Toupet, Esophagitis, GERD.
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INTRODUCTION
The application of a laparoscopic approach to anti-reflux
surgery was inevitable after the obvious success of
laparoscopic cholecystectomy. As equipment and tech-
nique became more refined, minimal access surgery was
applied to appendectomy, hernia repair, colon and small
bowel surgery. Initial publications showed good results
and a safety record that encouraged surgeons in com-
munity hospitals to learn and apply these approaches.
My initial approach was to use the laparoscopic Nissen-
Rossetti and Toupet fundoplication for the treatment of
gastroesophageal reflux disease (GERD) refractory to
medical management. This report describes the experi-
ence and the results of treatment of 100 consecutive
patients who underwent laparoscopic Nissen-Rossetti or
Toupet fundoplication in a community hospital.
MATERIALS AND METHODS
Laparoscopic anti-reflux surgery was performed on 30
male and 70 female patients with symptomatic GERD
between May 1994 and October 1996. Follow-up was
achieved on 98% of patients. The length of follow-up
ranged from 4 to 33 months with a mean follow-up of
17.6 months. All operations were accomplished by
myself in three community hospitals in the Pensacola,
Florida region: Gulf Breeze Hospital (n=5), Santa Rosa
Medical Center, (n=62), and Columbia West Florida
Regional Medical Center (n=33). All patients had signif-
icant symptoms from GERD, which were affecting their
family life, work performance and sense of well-being.
All patients had failed maximum medical management.
1-
6
Several had advanced GERD: strictures (n=5), Barrett's
esophagus (n=16). Six patients also had adult onset asth-
ma as one of their significant symptoms
7-
9 (Figure 1).
Prior to consideration for surgery, all patients had been
treated with antacids, H2 or acid pump blockers, pro-
motility agents, behavior and dietary modifications.
1-
3
Patients ranged in age from 14 to 73 years with a mean
age of 48.8 years, and in weight from 114 to 289 pounds
with a mean weight of 181.6 pounds. All patients
underwent a thorough history and physical examination.
Duration of symptoms ranged from 18 months to life-
long. All patients underwent upper gastrointestinal
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Figure 1. Advanced symptoms.
endoscopy with biopsies, and 98 patients underwent
esophageal manometry. All esophageal manometries
were accomplished by gastroenterologists using Norcan
water perfusion catheters and standard technique. Two
patients were unable to tolerate esophageal manometry.
Patients with Grades II to III esophagitis were vigorously
treated and rescoped to document healing at least to
Grade I esophagitis prior to surgery, decreasing the
chance of esophageal perforation. Esophageal manome-
try showed an abnormally low lower esophageal sphinc-
ter (LES) pressure (<20) in 97 patients.
10-1
2
Amplitude of esophageal contractions and progression of
waves were carefully noted and used as criteria for selec-
tion of Toupet fundoplication.
13-1
7 If the amplitude of
contraction was 60 or less with poor progression of
waves, the patient was considered to have a secondary
esophageal motility disorder and was selected for a
Toupet partial fundoplication. Patients unable to tolerate
esophageal manometry or those with a history of lupus
erythematosus or other connective tissue disorder were
offered Toupet fundoplication because of possible future
deterioration of esophageal function.
Twenty-four hour pH was used selectively in patients
who were not clearly diagnosed by history, endoscopy
and manometry (n=19).
1
2 DeMeester scores ranged from
14.8 to 290 with a mean score of 46.6.
Nissen-Rossetti fundoplications were performed on 70
patients and Toupet fundoplications on 30 patients.
LAPAROSCOPIC SURGICAL TECHNIQUE
The patient is requested to void immediately prior to
laparoscopic anti-reflux surgery so that no Foley catheter
is necessary. A standard peripheral vein IV access is
placed, and the patient undergoes general endotracheal
anesthesia. Antibiotics are not routinely used. An 18 Fr
NG is now placed and removed prior to extubation.
Bilateral sequential pneumatic anti-embotic stockings are
placed on all patients and removed once the patient is
ambulatory, usually two to three hours after surgery.
Pre-emptive analgesia is used on all patients.
1
8 All trocar
sites are marked out and then infiltrated with 0.25%
Marcaine with 1/200.000 Epinephrine. With the surgeon
to the right and the assistant to the left of the patient, the
scrub nurse stands on the right side, passes instruments
and operates the Welch-Allen Omni-Vue scope, which
gives an adjustable view in four directions from 0 to 90
degrees. A Hasson open technique is used to access the
abdominal cavity in the infraumbilical position.
Thereafter, the 5 and 10 mm trocars are placed under
direct vision. Sixty-five patients had undergone previous
abdominal surgery and many required lysis of adhesions.
An exploratory laparoscopy is completed, then the
patient is placed in slight flexion and in reverse
Trendelenburg position. The fundus is identified and
pulled inferiorly and laterally reducing the hiatal hernia
present in the majority of patients (n=79). Now, the sub-
hiatal fat pad is grasped and pulled inferiorly and to the
left. The "window" in the gastrohepatic ligament is iden-
tified.
The window is infiltrated, and the underlying hiatus, cau-
date lobe and right cruse are sprayed with 1% Xylocaine
1/100,000 epinephrine. The peritoneal reflection and
phenoesophageal ligament over the anterior border of
the esophagus is identified and elevated. This subperi-
toneal space is infiltrated with Xylocaine, which dissects
the tissue plane laterally left and posteriorly down over
the left crus. This is done as an extension of the pre-
emptive analgesia, which blocks the sensory nerves prior
to stimulation, helps dissect the proper tissue planes, and
significantly reduces intraoperative bleeding. The win-
dow in the gastrohepatic omentum is now divided using
an L-hook electrocautery up to the hiatus. The peri-
toneal refection over the anterior portion of the esopha-
gus is divided from right to left and down on to the left
crus. The left crus is well dissected, as this greatly
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decreases the difficulty and time spent on the retroe-
sophageal dissection. Now, the peritoneal refection over
the right crus is opened, then the right crus is dissected
away from the esophagus and the junction of the poste-
rior esophagus and right crus identified. The right crus
is dissected down to its junction with the left crus. The
subhiatal fat pad is now pulled anteriorly, and dissection
of the retroesophageal connective tissue is accomplished
using blunt bowel grasping clamps. Points of reference
are the posterior gastric fundus caudad and the left crus
superiorly. Once the left side has been accessed, a large
vessel loop is passed from the left to the right and held
by an endoloop 1 cm from the anterior esophagus. The
vessel loop is grasped and used to manipulate the esoph-
agus; at no time is the esophagus grasped by an instru-
ment.
The vessel loop serves to move the esophagus in an
atraumatic fashion and guarantees that the fundic wrap
will be above the esophagogastric junction, thus avoid-
ing the so-called "slipped Nissen."
With the right and left crus now well identified, the pos-
terior vagus nerve is identified visually, or by touch if it
is adherent to the posterior esophagus, and preserved.
The retroperitoneal gastric attachments are taken down
to free the posterior fundus and enlarge the retroe-
sophageal opening. A 52 Fr bougie is placed into the
intrathoracic esophagus alongside the indwelling 18 Fr
NG tube. Next, all tension is released on the esophagus
as the bougie is oscillated and slowly advanced under
direct vision and with continuous communication with
the nurse anesthetist.
This level of cooperation is necessary to prevent
esophageal perforation. The gastric body is palpated
with the blunt grasping forcep to determine proper posi-
tioning of the tip of the bougie.
The esophagus is elevated using the vessel loop and is
felt to be heavy and distended by the bougie and NG
tube. The superior portion of the fundus is selected and
grasped with a babcock and positioned near the left crus.
The fundus is grasped with forceps placed from right to
left posterior to the esophagus, and the fundus is pulled
to the right and anterior. The fundus is then released and
does not retract, indicating no tension on the wrap. If
the fundus does retract, further dissection is accom-
plished on the posterior gastric attachments and the gas-
trolienal ligament between the fundus and superior pole
of the spleen, which is well developed in about half of
the patients. When further dissection is required, the
bougie is retracted into the intrathoracic esophagus to
decrease the risk of esophageal perforation.
19,2
0 The
right portion of the fundus is once again grasped and
pulled anterior and the left anterior portion of the fundus
is grasped. These are then moved right and left while
the fundus slides behind the esophagus. At this point,
tactile and visual assessments are made to determine the
correct position of the left portion of the fundus that
ensures the wrap is floppy. Now, the right and left por-
tions of the fundus are grasped with one babcock, and a
0 Ethibond non-absorbable suture is placed seromuscu-
lar in the left fundus, muscular layer of esophagus, and
seromuscular in the right fundus and tied intracorporeal-
ly using the Endo-Stitch device. The babcock is released,
and two more identical sutures are placed. The Bougie
is rotated 360 degrees after each suture is placed to be
certain it is not incorporated in the suturing process. The
Bougie and NG tube are now removed. The wrap is
measured and found to be 1.5 to 2.0 cm in length. A
bowel grasper is placed between the wrap and esopha-
gus and elevated to ensure the wrap is floppy. Using this
technique, no patients required division of the short gas-
tric vessels to achieve a tension-free wrap.
The table is placed in the normal position. The instru-
ments are removed and all 10 to 12 mm trocar sites are
closed using the Exit device with 0-Vicryl suture to
achieve a closure of peritoneum and fascia. The skin is
closed with staples.
The patient receives Toradol 30 mg IV at the conclusion
of the surgery.
TOUPET PROCEDURE
The Toupet fundoplication is accomplished with the
identical port placement, dissection and bougie use, as
the Nissen fundoplication. The wrap is accomplished by
first suturing the seromuscular layer of gastrum to the left
crus using 0 Ethibond and then to the right crus, both to
close the hiatal hernia and to anchor the wrap posterior-
ly. Now, a 52 Fr bougie is advanced alongside the NG
tube to fill the esophagus. On the right, three sutures are
placed through the muscular layer of the esophagus and
seromuscular layers of the stomach. Next, three identi-
cal sutures are placed on the left, with care taken to
avoid the anterior vagus nerve. This completes the 200
to 220 degree wrap. The bougie and NG tube are rotat-
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ed and removed. The fundoplication is measured to be
1.5 to 2 cm in length, and the wrap is checked to be cer-
tain it is floppy.
Postoperatively, the patient receives a clear liquid diet
starting immediately after surgery. Pain control is accom-
plished with Toradol 30 mg IV immediately postopera-
tively, then 10 mg po qid and either percocet or
Mephergan Fortis prn. The IV and the pneumatic com-
pression hose are removed when the patient becomes
ambulatory. Incentive spirometry and deep breathing are
routine.
The next morning the patient receives a soft diet, and if
the diet is well tolerated and pain is controlled adequate-
ly, the patient is discharged that day. Dietary restrictions
are as follows: no extremely hot or cold fluids, no bread,
no steak, no chicken and no carbonated beverages for
three to four weeks. The majority of patients do not
restrict themselves to this for more than two weeks.
RESULTS
Follow-up was achieved in 98 out of 100 patients. Length
of follow-up ranged from 4 to 33 months with a mean fol-
low-up of 17.6 months. Operative times ranged from 75
to 240 minutes, with a mean time of 132 minutes. No
patients required conversion to an open procedure.
There were no cases of esophageal, gastric or splenic
injury or pneumothorax. There were no combined pro-
cedures other than umbilical herniorrhaphy when indi-
cated at the camera port. No patients developed gas
bloat syndrome. The mortality rate was zero. No
patients required reoperation for reflux disease.
Major complications were limited to one patient who
developed both a pulmonary embolus and a small bowel
perforation and required subsequent surgery. Minor
complications were limited to one patient who had
atelectasis with a mild temperature elevation, which
delayed discharge by one day. Ninety-six percent of
patients had a hospital stay of less than two days; 99%
had a hospital stay of less than three days, with a mean
hospital stay of 1.85 days.
Postoperative problems included two patients with
aerophagia, which improved over time. Two patients
complained of dysphagia. Esophagrams were normal,
and a barium tablet passed without difficulty in both
patients. These patients underwent upper endoscopy
and had balloon dilatation up to 54 French without any
resistance. One of these patients is under treatment for
esophageal spasm, which is episodic and stress related
and was present prior to surgery. A postoperative 24-
hour pH showed a DeMeester score of 4.7. The other
patient has become asymptomatic over time with no fur-
ther treatment. One patient had early satiety and bloat-
ing. A gastric emptying study was positive for gastro-
paresis, and the patient is currently being treated with
promotility agents. Three patients developed complaints
consistent with biliary colic. Ultrasounds of the
abdomen were normal. A HIDA Scan with CCK showed
low ejection fractions consistent with biliary dyskinesia
and these patients underwent laparoscopic cholecystec-
tomy. All had complete resolution of their symptoms.
Results of a follow-up patient questionnaire are listed in
Table 1.
Table 1.
Patient Questionnaire Results
Are your symptoms relieved?
97% Yes (3% had biliary dyskinesia)
Rate your results.
98% Excellent or Good
Has heartburn returned?
82% No; 14% Occasionally; 4% Yes;
96% No or Occasionally
Do you have trouble burping?
91% No; 9% Yes
Number of days until normal eating?
80% at 30 days; 95% at 60 days; 100% at 90 days
Do you have trouble swallowing?
98% No; 2% Yes
Do family members have same problem?
45% Yes; 55% No
Knowing what you now know, would you have surgery?
100% Yes
Would you recommend this surgery to a family or friends?
99% Yes
Rate your satisfaction of the surgical experience and your
results on a scale of 1 to 10.
mean score of 9.4
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DISCUSSION
These results are consistent with previously published
studies that show laparoscopic anti-reflux surgery to be
a safe and effective treatment for GERD.
19,2
1
The advantages of minimally invasive surgery for this
problem are reduced hospital stay, much less postopera-
tive pain, quicker return to normal activities and
improved cosmesis.
22,2
3 All these advantages factor into
the increased overall acceptance of patients electing to
undergo surgery for reflux disease. The increased pres-
sures of cost containment for medical care make the
laparoscopic approach likely to emerge as the preferred
treatment for GERD when compared to laparotomy and
prolonged medical management.
24-2
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The adverse reaction rate of long-term medical manage-
ment is approximately 4% with H2 Blockers and rises to
14% with Omeprazole. This includes drug interactions
with commonly prescribed drugs such as theophylline,
warfarin, phenytoin and benzodiazepines.
2
With a surgical complication rate of 2% in this series,
which is less than the 4% to 14% complication rate of
long-term medical management, laparoscopic anti-reflux
surgery becomes a much more appealing option for
patients and their referring physicians.
In this series of 100 patients, none have prolonged dys-
phagia as a result of their surgery. The short-term dys-
phagia attributed to postoperative edema and
esophageal irritability causing spasm passes in time, with
80% eating normally by 30 days, 95% by 60 days and
100% by 90 days.
Few studies have looked at the relationship among
esophageal motility, type of operation and postoperative
dysphagia.
27-2
9
Bremner's study
2
7 shows a postoperative dysphagia
prevalence of 19% and concludes that nonspecific
esophageal motility disorders have no effect on postop-
erative dysphagia. All Bremner's patients had Nissen
fundoplications, and a dysphagia rate of 19% is a signif-
icant finding.
With the selective use of Toupet fundoplication for
patients with less than 60 mm Hg amplitude of contrac-
tions, this series of 100 patients has no long-term post-
operative dysphagia.
In conclusion, with proper selection, laparoscopic
Nissen-Rossetti or Toupet fundoplication is a highly
effective, safe and curative operation for patients with
gastroesophageal reflux disease refractory to medical
management.
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